Predictive Value of Preoperative Assessment Tools for Perioperative Major Adverse Cardiac Event in Patients Undergoing Noncardiac Surgery

Guang-yan XU; Li XU; Zi-jia LIU; Yu-guang HUANG

doi:10.3969/j.issn.1674-9081.2019.05.016

Volume 10 Issue 5

Turn off MathJax

Article Contents

Abstract

References

Medical Journal of Peking Union Medical College Hospital > 2019 > 10(5): 518-523. > DOI: 10.3969/j.issn.1674-9081.2019.05.016

Guang-yan XU, Li XU, Zi-jia LIU, Yu-guang HUANG. Predictive Value of Preoperative Assessment Tools for Perioperative Major Adverse Cardiac Event in Patients Undergoing Noncardiac Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 518-523. DOI: 10.3969/j.issn.1674-9081.2019.05.016

Citation:

PDF (387 KB)

Predictive Value of Preoperative Assessment Tools for Perioperative Major Adverse Cardiac Event in Patients Undergoing Noncardiac Surgery

Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information

Corresponding author:
HUANG Yu-guang Tel: 86-10-69152100, E-mail:garybeijing@163.com
Received Date: March 24, 2019
Issue Publish Date: September 29, 2019

Graphical Abstract

Abstract

Abstract

The major adverse cardiac event (MACE) in patients undergoing noncardiac surgery is associated with a marked increase in morbidity and mortality. It is critical to use appropriate assessment tools preoperatively to assess the risk of major adverse cardiac event in patients undergoing noncardiac surgery. We already have guidelines and expert consensus to guide the risk stratification for perioperative major adverse cardiac events in patients undergoing noncardiac surgery. Revised Cardiac Risk Index, the American College of Surgeons' National Surgical Quality Improvement Program Myocardial Infarction or Cardiac Arrest Risk Calculator, and the American College of Surgeons' National Surgical Quality Improvement Program Surgical Risk Calculator are currently common assessment tools used for perioperative major adverse cardiac events in patients undergoing noncardiac surgery. Currently, we have no relevant research on analyzing the applicable conditions, evaluating the merits and demerits of those assessment tools, and comparing the predictive values on perioperative major adverse cardiac events in patients undergoing noncardiac surgery. In this article, we review some domestic and foreign literature in recent years, attempting to summarize the performance of these assessment toolsin patients undergoing noncardiac surgery. We also aim to provide a guide for doctors to find the most optimal preoperative assessment tool.
- surgery,
- perioperative period,
- risk assessment tools

FullText(HTML)

References (40)

References

[1]	Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012:an assessment supporting improved health outcomes[J]. Lancet, 2015, 385:S11. https://www.ncbi.nlm.nih.gov/pubmed/?term=Estimate+of+the+global+volume+of+surgery+in+2012%3A+an+assessment+supporting+improved+health+outcomes
[2]	Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery:a modelling strategy based on available data[J]. Lancet, 2008, 372:139-144. https://pubmed.ncbi.nlm.nih.gov/18582931/
[3]	Devereaux PJ, Sessler DI. Cardiac Complications in Patients Undergoing Major Noncardiac Surgery[J]. N Engl J Med, 2015, 373:2258-2269. https://www.ncbi.nlm.nih.gov/pubmed/26630144
[4]	Roshanov PS, Walsh M, Devereaux PJ, et al. External validation of the revised cardiac risk index and update of its renal variable to predict 30-day risk of major cardiac complications after non-cardiac surgery:rationale and plan for analyzes of the VISION study[J]. BMJ Open, 2017, 7:e013510. https://pubmed.ncbi.nlm.nih.gov/28069624/
[5]	Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery:a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes[J]. Anesthesiology, 2014, 120:564-578. https://pubmed.ncbi.nlm.nih.gov/24534856/
[6]	Pannell LM, Reyes EM, Underwood SR. Cardiac risk assessment before non-cardiac surgery[J]. Eur Heart J Cardiovasc Imaging, 2013, 14:316-322.
[7]	Udeh BL, Dalton JE, Hata JS, et al. Economic trends from 2003 to 2010 for perioperative myocardial infarction:a retrospective, cohort study[J]. Anesthesiology, 2014, 121:36-45. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW201705250134546
[8]	Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2014, 130:2215-2245. https://pubmed.ncbi.nlm.nih.gov/?term=25085961
[9]	Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery:cardiovascular assess-ment and management:The Joint Task Force on noncardiac surgery:cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)[J]. Eur Heart J, 2014, 35:2383-2431. DOI: 10.1007/s12350-016-0642-9
[10]	Duceppe E, Parlow J, Macdonald P, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery[J]. Can J Cardiol, 2017, 33:17-32. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=b0e48b5b5517f4cec0c3211b3e33c908
[11]	中华医学会麻醉学分会编.中国麻醉学指南与专家共识[M].北京:人民卫生出版社, 2017:75-87.
[12]	Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery[J]. Circulation, 1999, 100:1043-1049. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW201705250306778
[13]	Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial):a randomised controlled trial[J]. Lancet, 2008, 371:1839-1847. https://www.sciencedirect.com/science/article/pii/S0140673608606017
[14]	Hoftman N, Prunean A, Dhillon A, et al. Revised Cardiac Risk Index (RCRI) is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients[J]. Transplantation, 2013, 96:639-643. https://www.researchgate.net/publication/249966032_Revised_Cardiac_Risk_Index_RCRI_Is_a_Useful_Tool_for_Evaluation_of_Perioperative_Cardiac_Morbidity_in_Kidney_Transplant_Recipients
[15]	Ford MK, Beattie WS, Wijeysundera DN. Systematic review:prediction of perioperative cardiac complications and mortality by the revised cardiac risk index[J]. Ann Intern Med, 2010, 152:26-35. https://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12010000307&ID=12010000307
[16]	Wotton R, Marshall A, Kerr A, et al. Does the revised cardiac risk index predict cardiac complications following elective lung resection?[J]. Cardiothora Surg, 2013, 8:220-220. DOI: 10.1186/1749-8090-8-220
[17]	Smeili LAA, Lotufo PA. Incidence and Predictors of Cardiovascular Complications and Death after Vascular Surgery[J]. Arq Bras De Cardiol, 2015, 105:510-518. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000004130683
[18]	Payne CJ, Bryce GJ, Gibson SC, et al. The Revised Cardiac Risk Index performs poorly in patients undergoing major vascular surgery:a prospective observational study[J]. Eur J Anaesthesiol, 2013, 30:713-715.
[19]	Devereaux PJ, Chan MTV, Walsh M, et al. An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery:the VISION Pilot Study[J]. Open Med, 2011, 5:e193-e200.
[20]	Che L, Xu L, Huang Y, et al. Clinical utility of the revised cardiac risk index in older Chinese patients with known coronary artery disease[J]. Clin Interv Aging, 2017, 13:35-41. https://www.dovepress.com/clinical-utility-of-the-revised-cardiac-risk-index-in-older-chinese-pa-peer-reviewed-article-CIA
[21]	Biccard B. Proposed research plan for the derivation of a new Cardiac Risk Index[J]. Anesth Analg, 2015, 120:543-553.
[22]	Davis C, Tait G, Carroll J, et al. The Revised Cardiac Risk Index in the new millennium:a single-centre prospective cohort re-evaluation of the original variables in 9, 519 consecutive elective surgical patients[J]. Can J Anesth, 2013, 60:855-863. DOI: 10.1007/s12630-013-9988-5
[23]	Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery[J]. Circulation, 2011, 124:381-387. DOI: 10.1161/CIRCULATIONAHA.110.015701
[24]	Peterson B, Ghahramani M, Harris S, et al. Usefulness of the Myocardial Infarction and Cardiac Arrest Calculator as a Discriminator of Adverse Cardiac Events After Elective Hip and Knee Surgery[J]. Am J Cardiol, 2016, 117:1992-1995. DOI: 10.1016/j.amjcard.2016.03.050
[25]	Cohn SL, Ros NF. Comparison of 4 Cardiac Risk Calculators in Predicting Postoperative Cardiac Complications after Noncardiac Operations[J]. Am J Cardiol, 2018, 121:125-130. DOI: 10.1016/j.amjcard.2017.09.031
[26]	Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator:a decision aid and informed consent tool for patients and surgeons[J]. Am Coll Surg, 2013, 217:833-842. DOI: 10.1016/j.jamcollsurg.2013.07.385
[27]	Cohen ME, Liu Y, Ko CY, et al. An Examination of American College of Surgeons NSQIP Surgical Risk Calculator Accuracy[J]. Am Coll of Surg, 2017, 224:787-795. DOI: 10.1016/j.jamcollsurg.2016.12.057
[28]	Kazaure HS, Roman SA, Rosenthal RA, et al. Cardiac arrest among surgical patients:an analysis of incidence, patient characteristics, and outcomes in ACS-NSQIP[J]. JAMA Surg, 2013, 148:14-21. https://pubmed.ncbi.nlm.nih.gov/23324834/
[29]	Buschmann CT, Tsokos M. Frequent and rare complications of resuscitation attempts[J]. Intensive Care Med, 2009, 35:397-404. DOI: 10.1007/s00134-008-1255-9
[30]	Prasad KG, Nelson BG, Deig CR, et al. ACS NSQIP risk calculator:an accurate predictor of complications in major head and neck surgery?[J]. Otolaryngol Head Neck Surg, 2016, 155:740-742. DOI: 10.1177/0194599816655976
[31]	Schneider AL, Deig CR, Prasad KG, et al. Ability of the National Surgical Quality Improvement Program Risk Calculator to predict complications following total laryngectomy[J]. JAMA Otolaryngol Head Neck Surg, 2016, 142:972-979. DOI: 10.1001/jamaoto.2016.1809
[32]	Arce K, Moore EJ, Lohse CM, et al. The American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator does not accurately predict risk of 30-day complications among patients undergoing microva-scular head and neck reconstruction[J]. Oral Maxillofac Surg, 2016, 74:1850-1858. DOI: 10.1016/j.joms.2016.02.024
[33]	Teoh D, Halloway RN, Heim J, et al. Evaluation of the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator in gynecologic oncology patients undergoing minimally invasive surgery[J]. Minim Invasive Gynecol, 2017, 24:48-54. DOI: 10.1016/j.jmig.2016.10.005
[34]	Rivard C, Nahum R, Slagle E, et al. Evaluation of the performance of the ACS NSQIP surgical risk calculator in gynecologic oncology patients undergoing laparotomy[J]. Gynecol Oncol, 2016, 141:281-286. DOI: 10.1016/j.ygyno.2016.02.015
[35]	Szender JB, Frederick PJ, Eng KH, et al. Evaluation of the National Surgical Quality Improvement Program Universal Surgical Risk Calculator for a gynecologic oncology service[J]. Int Gynecol Cancer, 2015, 25:512-520. DOI: 10.1097/IGC.0000000000000378
[36]	O'Neill AC, Bagher S, Barandun M, et al. Can the American College of Surgeons NSQIP surgical risk calculator identify patients at risk of complications following microsurgical breast reconstruction?[J]. Plast Reconstr Aesthet Surg, 2016, 69:1356-1362. DOI: 10.1016/j.bjps.2016.05.021
[37]	Liu Y, Cohen ME, Hall BL, et al. Evaluation and enhancement of calibration in the American College of Surgeons NSQIP Surgical Risk Calculator[J]. Am Coll Surg, 2016, 223:231-239. DOI: 10.1016/j.jamcollsurg.2016.03.040
[38]	Greenhalgh RM, Brown LC, Powell JT, et al. Endovascular versus open repair of abdominal aortic aneurysm[J]. N Engl Med, 2010, 362:1863-1871. DOI: 10.1056/NEJMoa0909305
[39]	Rodseth RN, Lurati Buse GA, Bolliger D, et al. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events:an individual patient data meta-analysis[J]. Am Coll Cardiol, 2011, 58:522-529. DOI: 10.1016/j.jacc.2011.04.018
[40]	Devereaux PJ, Chan MT, Alonso-Coello P, et al. Associa-tion between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery[J]. JAMA, 2012, 307:2295-2304. DOI: 10.1001/jama.2012.5502

[1]	YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer ⁶⁸Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
[2]	ZHANG Qian, WANG Haidong, YANG Huijun, JIN Fangmei, KAN Lili, BAI Songsong. Exploring the Mechanism and Intervention Strategies of Osteoporosis Based on the TLR4 Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0536
[3]	ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
[4]	LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
[5]	Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, Chinese Society of Endocrinology PET group, Chinese Society of Nuclear Medicine. Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 986-991. DOI: 10.12290/xhyxzz.2022-0584
[6]	XIAO Nan, LI Zhanfeng, YAO Jianxin, PAN Zhiyao, YAO Zhifeng. Long Non-coding RNA and Cancer Stem Cells[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 373-379. DOI: 10.12290/xhyxzz.20190231
[7]	Ya-ping LUO, Fang LI, Miao YU, Xiao-ping XING, Tai-ping ZHANG, Yu-pei ZHAO. Procedure Guideline of Glucagon-like Peptide-1 Receptor Positron Emission Tomography/Computed Tomography in Localizing Insulinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 486-491. DOI: 10.3969/j.issn.1674-9081.2020.04.022
[8]	Ju QIAO, Feng LI, Chun-xia HE, Chao WU, Hong-zhong JIN. Effects of the Receptor-IgG Fc Fusion Protein of Recombinant Type Ⅱ Human Tumor Necrosis Factor-α on the Levels of Serum Adipokines in Psoriatic Patients: A Prospective Non-randomized Controlled Trial[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 243-248. DOI: 10.3969/j.issn.1674-9081.2019.03.010
[9]	Ling YUAN, Zheng-Yu JIN. Paul C. Hodges and the Early Development of Radiology in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 91-94. DOI: 10.3969/j.issn.1674-9081.2019.01.015

Cited By

Cited by

Periodical cited type(7)

1.	周秋萍. 肿瘤新抗原疫苗的研究现状. 生物化工. 2020(05): 154-155+159 .
2.	张家齐，刘磊，王桂阁，白文梁，李单青. 非小细胞肺癌跳跃性N2淋巴结转移的临床病理特点及预后. 协和医学杂志. 2019(03): 272-277 . 本站查看
3.	吕丹，王柏山，李娅丽，张程，金迪. 探讨肺癌患者肿瘤标志物CYFRA21-1、CEA、CA12-5、NSE与中医辨证分型之间的相关性. 辽宁中医药大学学报. 2019(06): 165-167 .
4.	袁飞，王新乐，张灿，吴显宁，徐美青. NSCLC肿瘤及癌旁组织CD4~+和CD8~+T细胞PD-1的表达及意义. 安徽医科大学学报. 2019(08): 1295-1298 .
5.	王贝茹，张思远，魏陈秋. 肿瘤免疫治疗的研究现状及应用. 中外医学研究. 2019(22): 184-186 .
6.	汪梅花，赵康，葛繁梅. 成人急性髓系白血病患者化疗后发生院内感染的影响因素. 中国医刊. 2019(09): 993-995 .
7.	王汉萍，宋鹏，斯晓燕，郭潇潇，李玥，周佳鑫，段炼，张丽，王孟昭，张力. 危重及难治性免疫检查点抑制剂相关毒性反应诊治建议及探索. 中国肺癌杂志. 2019(10): 605-614 .

Other cited types(10)

Get Citation

PDF

XML

Article Metrics

Article views (367) PDF downloads (175) Cited by(17)

Address：	Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
Tel：	010-69154261/4262
E - mail：	medj@pumch.cn mjpumch@126.com
Copyright of website：	Editorial Office of Medical Journal of Peking Union Medical College Hospital

Predictive Value of Preoperative Assessment Tools for Perioperative Major Adverse Cardiac Event in Patients Undergoing Noncardiac Surgery

Abstract

References

Related Articles

Cited by

Periodical cited type(7)

Other cited types(10)

Catalog

Article Metrics

Related

Predictive Value of Preoperative Assessment Tools for Perioperative Major Adverse Cardiac Event in Patients Undergoing Noncardiac Surgery

Abstract

References

Related Articles

Cited by

Periodical cited type(7)

Other cited types(10)

Catalog

Article Metrics

Related

Export File

Citation

Format

Content